109 related articles for article (PubMed ID: 8855188)
1. Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 1. Morphology and inhibition of fibrogenesis by dipyridamole.
Wanless IR; Belgiorno J; Huet PM
Hepatology; 1996 Oct; 24(4):855-64. PubMed ID: 8855188
[TBL] [Abstract][Full Text] [Related]
2. Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 2. Hemodynamic and drug disposition studies.
Mastaï R; Laganière S; Wanless IR; Giroux L; Rocheleau B; Huet PM
Hepatology; 1996 Oct; 24(4):865-70. PubMed ID: 8855189
[TBL] [Abstract][Full Text] [Related]
3. [Ultrastructural dynamic observation on murine schistosomal hepatic fibrosis].
Wang XL; Zhang LM; Tang FX; Guo ZW; Wu CY; Xiong ZJ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2002; 20(4):216-9. PubMed ID: 12568023
[TBL] [Abstract][Full Text] [Related]
4. Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat.
Abe W; Ikejima K; Lang T; Okumura K; Enomoto N; Kitamura T; Takei Y; Sato N
J Hepatol; 2007 Feb; 46(2):286-94. PubMed ID: 17166617
[TBL] [Abstract][Full Text] [Related]
5. [Role of hepatic sinusoidal endothelium injury in hepatic fibrogenesis induced by dimethylnitrosamine in rats].
Lu X; Liu P; Liu C; Xu G; Wang X; Chen W; Li F
Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):441-4. PubMed ID: 12502448
[TBL] [Abstract][Full Text] [Related]
6. Experimental study of the reversibility of sinusoidal capillarization.
Mori T; Okanoue T; Kanaoka H; Sawa Y; Kashima K
Alcohol Alcohol Suppl; 1994; 29(1):67-74. PubMed ID: 9063822
[TBL] [Abstract][Full Text] [Related]
7. [Expression of integrin alpha 6 in hepatic sinusoidal capillaration].
Xiao W; Wang Y; Liu X; Huang M; Gan T
Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):90-2. PubMed ID: 11983119
[TBL] [Abstract][Full Text] [Related]
8. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats.
Boigk G; Stroedter L; Herbst H; Waldschmidt J; Riecken EO; Schuppan D
Hepatology; 1997 Sep; 26(3):643-9. PubMed ID: 9303494
[TBL] [Abstract][Full Text] [Related]
9. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
10. Hepatic fibrogenesis using chronic arsenic ingestion: studies in a murine model.
Sarin SK; Sharma G; Banerjee S; Kathayat R; Malhotra V
Indian J Exp Biol; 1999 Feb; 37(2):147-51. PubMed ID: 10641134
[TBL] [Abstract][Full Text] [Related]
11. [Pathogenesis of liver fibrosis in patients with chronic hepatitis B].
Shi J; Hao JH; Ren WH; Zhu JR; Wang SY; Xie YB
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):443-5. PubMed ID: 19567024
[TBL] [Abstract][Full Text] [Related]
12. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
Hu YB; Li DG; Lu HM
J Gene Med; 2007 Mar; 9(3):217-29. PubMed ID: 17351970
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
14. Antifibrotic and hemodynamic effects of the early and chronic administration of octreotide in two models of liver fibrosis in rats.
Fort J; Oberti F; Pilette C; Veal N; Gallois Y; Douay O; Rousselet MC; Rosenbaum J; Calès P
Hepatology; 1998 Dec; 28(6):1525-31. PubMed ID: 9828216
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a reproducible rat model of hepatic veno-occlusive disease.
DeLeve LD; McCuskey RS; Wang X; Hu L; McCuskey MK; Epstein RB; Kanel GC
Hepatology; 1999 Jun; 29(6):1779-91. PubMed ID: 10347121
[TBL] [Abstract][Full Text] [Related]
16. Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats.
Shimizu I; Ma YR; Mizobuchi Y; Liu F; Miura T; Nakai Y; Yasuda M; Shiba M; Horie T; Amagaya S; Kawada N; Hori H; Ito S
Hepatology; 1999 Jan; 29(1):149-60. PubMed ID: 9862861
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid receptor antagonist spironolactone prevents pig serum-induced hepatic fibrosis in rats.
Fujisawa G; Muto S; Okada K; Kusano E; Ishibashi S
Transl Res; 2006 Sep; 148(3):149-56. PubMed ID: 16938653
[TBL] [Abstract][Full Text] [Related]
18. Pentoxifylline prevents pig serum-induced rat liver fibrosis by inhibiting interleukin-6 production.
Toda K; Kumagai N; Kaneko F; Tsunematsu S; Tsuchimoto K; Saito H; Hibi T
J Gastroenterol Hepatol; 2009 May; 24(5):860-5. PubMed ID: 19220679
[TBL] [Abstract][Full Text] [Related]
19. Characterization of hepatic iron overload following dietary administration of dicyclopentadienyl iron (Ferrocene) to mice: cellular, biochemical, and molecular aspects.
Valerio LG; Petersen DR
Exp Mol Pathol; 2000 Feb; 68(1):1-12. PubMed ID: 10640449
[TBL] [Abstract][Full Text] [Related]
20. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice.
McCuskey RS; Ito Y; Robertson GR; McCuskey MK; Perry M; Farrell GC
Hepatology; 2004 Aug; 40(2):386-93. PubMed ID: 15368443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
